Hamps Bio, a company in the Other Agricultural Products industry, reported revenue of ₹7.31 crore and net profit of ₹0.20 crore for the September 2026 quarter.
Hamps Bio (BSE: HAMPS) closed at ₹25.50 on 20 Nov 2026, up 4.1% over the past year. Its market capitalisation is ₹22 crore.
Incorporated in 2007, Hamps Bio Ltd is in the business of Pharmaceutical Formulation and Freeze-Drying Ingredient Manufacturing and Distribution
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.